Analysts predict that Kraton Corp (NYSE:KRA) will post $536.75 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for Kraton’s earnings, with estimates ranging from $534.50 million to $539.00 million. Kraton posted sales of $538.40 million in the same quarter last year, which suggests a negative year-over-year growth rate of 0.3%. The business is scheduled to issue its next earnings results after the market closes on Wednesday, July 24th.
On average, analysts expect that Kraton will report full year sales of $2.00 billion for the current financial year, with estimates ranging from $1.99 billion to $2.01 billion. For the next fiscal year, analysts forecast that the company will report sales of $2.08 billion, with estimates ranging from $2.06 billion to $2.10 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Kraton.
Kraton (NYSE:KRA) last posted its quarterly earnings results on Wednesday, April 24th. The specialty chemicals company reported $0.88 EPS for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.23. The firm had revenue of $456.40 million for the quarter, compared to analysts’ expectations of $491.65 million. Kraton had a net margin of 2.93% and a return on equity of 15.20%. The business’s revenue for the quarter was down 9.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.58 earnings per share.
NYSE:KRA traded up $1.16 during mid-day trading on Thursday, reaching $30.22. The company’s stock had a trading volume of 146,060 shares, compared to its average volume of 225,082. Kraton has a 1 year low of $19.13 and a 1 year high of $50.20. The business’s fifty day simple moving average is $28.63. The stock has a market capitalization of $960.79 million, a price-to-earnings ratio of 9.56 and a beta of 2.33. The company has a debt-to-equity ratio of 1.85, a current ratio of 1.83 and a quick ratio of 0.78.
In related news, SVP Jose Fernando Cherubini Haddad sold 6,000 shares of the stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $33.10, for a total value of $198,600.00. Following the completion of the transaction, the senior vice president now directly owns 14,910 shares of the company’s stock, valued at approximately $493,521. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.32% of the company’s stock.
A number of large investors have recently modified their holdings of the stock. Mason Street Advisors LLC increased its holdings in Kraton by 3.3% in the 1st quarter. Mason Street Advisors LLC now owns 10,253 shares of the specialty chemicals company’s stock worth $330,000 after buying an additional 329 shares during the period. Ironwood Investment Management LLC increased its holdings in Kraton by 1.7% in the 1st quarter. Ironwood Investment Management LLC now owns 27,074 shares of the specialty chemicals company’s stock worth $871,000 after buying an additional 463 shares during the period. Rhumbline Advisers grew its stake in shares of Kraton by 0.7% during the 1st quarter. Rhumbline Advisers now owns 89,793 shares of the specialty chemicals company’s stock worth $2,890,000 after purchasing an additional 662 shares during the period. Versant Capital Management Inc grew its stake in shares of Kraton by 137.0% during the 1st quarter. Versant Capital Management Inc now owns 1,171 shares of the specialty chemicals company’s stock worth $37,000 after purchasing an additional 677 shares during the period. Finally, Texas Permanent School Fund grew its stake in shares of Kraton by 3.7% during the 1st quarter. Texas Permanent School Fund now owns 21,676 shares of the specialty chemicals company’s stock worth $698,000 after purchasing an additional 764 shares during the period. Institutional investors own 96.43% of the company’s stock.
Kraton Corporation manufactures and sells styrenic block copolymers and other engineered polymers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Polymer and Chemical. The Polymer segment offers performance products, including styrene-butadiene-styrene and styrene-isoprene-styrene; and specialty polymers, such as hydrogenated styrenic block copolymers, as well as isoprene rubber and isoprene rubber latex for use in medical and personal care products, adhesives, tackifiers, paints, and coatings.
Featured Article: What is a capital gain?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kraton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kraton and related companies with MarketBeat.com's FREE daily email newsletter.